Effect of Chronic Dolutegravir Administration on the Trace Amine Profile in Wistar Rats

Abstract Background Dolutegravir (DTG), an integrase strand inhibitor, is currently used as the first-line treatment for HIV. Despite relatively poor tissue penetration, the risk of adverse effects in metabolic and excretory systems should be considered. The trace aminergic system and trace amines a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natasha Henning (Autor), Tracy A. Kellermann (Autor), Carine Smith (Autor)
Formato: Libro
Publicado: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible